Cost analysis in treatment of Gynecological Cancer
Not Applicable
- Conditions
- Health Condition 1: C530- Malignant neoplasm of endocervixHealth Condition 2: C541- Malignant neoplasm of endometriumHealth Condition 3: C510- Malignant neoplasm of labium majusHealth Condition 4: C569- Malignant neoplasm of unspecifiedovaryHealth Condition 5: C574- Malignant neoplasm of uterine adnexa, unspecifiedHealth Condition 6: C55- Malignant neoplasm of uterus, partunspecifiedHealth Condition 7: C52- Malignant neoplasm of vagina
- Registration Number
- CTRI/2024/07/070008
- Lead Sponsor
- CMS and GTB Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
SUSPECTED/ DIAGNOSED GYNAECOLOGIC CANCER (CERVIX, UTERUS, OVARY,VAGINA, VULVA)
Exclusion Criteria
NON-GYNAECOLOGIC MALIGNANCIES
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Out-of-pocket expenditure(direct & indirect) <br/ ><br> <br/ ><br>Timepoint: baseline <br/ ><br>
- Secondary Outcome Measures
Name Time Method Catastrophic Health Expenditure RateTimepoint: baseline